Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 6 | 2020 | 63 | 2.070 |
Why?
|
| NADPH Oxidases | 5 | 2020 | 114 | 1.650 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 11 | 2020 | 232 | 1.520 |
Why?
|
| Muscle, Skeletal | 13 | 2021 | 937 | 1.480 |
Why?
|
| Membrane Glycoproteins | 5 | 2017 | 414 | 1.320 |
Why?
|
| Reactive Oxygen Species | 13 | 2020 | 477 | 1.220 |
Why?
|
| NADPH Oxidase 2 | 7 | 2020 | 40 | 1.200 |
Why?
|
| Autophagy | 6 | 2018 | 391 | 1.060 |
Why?
|
| Calcium | 14 | 2020 | 1094 | 0.880 |
Why?
|
| Oxidative Stress | 10 | 2021 | 796 | 0.740 |
Why?
|
| Ankyrins | 1 | 2021 | 99 | 0.700 |
Why?
|
| Calmodulin | 7 | 2002 | 228 | 0.690 |
Why?
|
| Diaphragm | 1 | 2018 | 97 | 0.560 |
Why?
|
| Microtubules | 1 | 2018 | 197 | 0.560 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 207 | 0.480 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 253 | 0.480 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 14 | 0.470 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2017 | 121 | 0.460 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 63 | 0.440 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 428 | 0.430 |
Why?
|
| Mice, Inbred mdx | 5 | 2020 | 40 | 0.430 |
Why?
|
| Computer Systems | 1 | 2013 | 38 | 0.430 |
Why?
|
| Molecular Imaging | 1 | 2013 | 61 | 0.410 |
Why?
|
| Apoptosis | 4 | 2017 | 1780 | 0.400 |
Why?
|
| Genes, Reporter | 1 | 2013 | 384 | 0.390 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2016 | 97 | 0.390 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 394 | 0.390 |
Why?
|
| Animals | 30 | 2021 | 33723 | 0.380 |
Why?
|
| Mice | 19 | 2021 | 17487 | 0.380 |
Why?
|
| Cardiomegaly | 3 | 2021 | 133 | 0.370 |
Why?
|
| Glutaredoxins | 2 | 2021 | 28 | 0.340 |
Why?
|
| Oxidation-Reduction | 6 | 2021 | 444 | 0.340 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2018 | 162 | 0.340 |
Why?
|
| Parkinson Disease | 1 | 2016 | 669 | 0.320 |
Why?
|
| Heart | 3 | 2019 | 725 | 0.310 |
Why?
|
| Aging | 5 | 2019 | 1172 | 0.260 |
Why?
|
| Rotenone | 2 | 2016 | 16 | 0.250 |
Why?
|
| Alternative Splicing | 2 | 2017 | 346 | 0.240 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 327 | 0.190 |
Why?
|
| Myocytes, Cardiac | 4 | 2021 | 617 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 4269 | 0.180 |
Why?
|
| In Vitro Techniques | 3 | 2013 | 966 | 0.180 |
Why?
|
| NADPH Oxidase 4 | 1 | 2020 | 15 | 0.180 |
Why?
|
| Cluster Analysis | 1 | 2021 | 400 | 0.170 |
Why?
|
| Fatigue | 1 | 2021 | 217 | 0.170 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 3277 | 0.170 |
Why?
|
| Signal Transduction | 6 | 2018 | 4495 | 0.160 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 9 | 0.160 |
Why?
|
| Cell Nucleus | 3 | 2017 | 674 | 0.160 |
Why?
|
| Dystrophin | 1 | 2018 | 37 | 0.160 |
Why?
|
| Models, Biological | 3 | 2017 | 1442 | 0.160 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2019 | 31 | 0.160 |
Why?
|
| Organogenesis | 1 | 2019 | 77 | 0.150 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 75 | 0.150 |
Why?
|
| Vasoconstriction | 1 | 2019 | 104 | 0.150 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 47 | 0.150 |
Why?
|
| Fluorescence | 2 | 2013 | 93 | 0.150 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 198 | 0.150 |
Why?
|
| src-Family Kinases | 1 | 2018 | 90 | 0.150 |
Why?
|
| Muscle Contraction | 1 | 2018 | 186 | 0.150 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 59 | 0.150 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 160 | 0.150 |
Why?
|
| Synapses | 1 | 2021 | 448 | 0.150 |
Why?
|
| Myocardium | 3 | 2019 | 982 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 490 | 0.140 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 58 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2017 | 2585 | 0.140 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 2390 | 0.140 |
Why?
|
| Heart Failure | 2 | 2021 | 2125 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 168 | 0.140 |
Why?
|
| Trehalose | 1 | 2017 | 20 | 0.140 |
Why?
|
| Calcineurin | 1 | 2017 | 100 | 0.140 |
Why?
|
| Phosphoproteins | 1 | 2019 | 399 | 0.140 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 12 | 0.140 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 74 | 0.140 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2016 | 23 | 0.140 |
Why?
|
| Heart Ventricles | 2 | 2019 | 765 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 144 | 0.140 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 54 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2021 | 765 | 0.130 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 121 | 0.130 |
Why?
|
| Calcium Signaling | 4 | 2019 | 241 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 531 | 0.130 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 214 | 0.130 |
Why?
|
| Glycolysis | 1 | 2016 | 141 | 0.130 |
Why?
|
| Chromatin | 1 | 2019 | 552 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 146 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 438 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 175 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2018 | 528 | 0.120 |
Why?
|
| Rabbits | 5 | 2002 | 696 | 0.120 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 707 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 457 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2021 | 3715 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 666 | 0.110 |
Why?
|
| Cytosol | 1 | 2013 | 159 | 0.110 |
Why?
|
| Carrier Proteins | 2 | 2017 | 1019 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2013 | 82 | 0.110 |
Why?
|
| Cells, Cultured | 5 | 2019 | 3047 | 0.110 |
Why?
|
| Macrophage Activation | 1 | 2013 | 61 | 0.110 |
Why?
|
| Cell Movement | 1 | 2016 | 831 | 0.110 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 50 | 0.110 |
Why?
|
| Electric Stimulation | 1 | 2013 | 315 | 0.100 |
Why?
|
| Heat Stress Disorders | 1 | 2012 | 10 | 0.100 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2012 | 24 | 0.100 |
Why?
|
| Ribonucleotides | 1 | 2012 | 36 | 0.100 |
Why?
|
| Hot Temperature | 1 | 2012 | 135 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 290 | 0.100 |
Why?
|
| Action Potentials | 3 | 2019 | 499 | 0.090 |
Why?
|
| Binding Sites | 4 | 2001 | 1292 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1265 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 803 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2001 | 317 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 165 | 0.090 |
Why?
|
| Hypertension | 1 | 2018 | 1284 | 0.080 |
Why?
|
| Male | 11 | 2021 | 60040 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 2047 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1907 | 0.080 |
Why?
|
| Calcium Channels, L-Type | 2 | 2016 | 53 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4346 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2017 | 1611 | 0.080 |
Why?
|
| Humans | 10 | 2018 | 123157 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2001 | 2698 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 3871 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2017 | 196 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2307 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2019 | 612 | 0.070 |
Why?
|
| Heart Rate | 2 | 2019 | 585 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2019 | 991 | 0.060 |
Why?
|
| Mutation | 2 | 2017 | 5773 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 382 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2017 | 416 | 0.060 |
Why?
|
| Time Factors | 1 | 2013 | 6204 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1680 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 78 | 0.050 |
Why?
|
| EF Hand Motifs | 1 | 2000 | 3 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2001 | 748 | 0.040 |
Why?
|
| Tryptophan | 1 | 2000 | 92 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 98 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 208 | 0.040 |
Why?
|
| Protein Binding | 2 | 2000 | 1743 | 0.040 |
Why?
|
| Kinetics | 1 | 2001 | 1313 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2000 | 194 | 0.040 |
Why?
|
| Diploidy | 1 | 2019 | 35 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2019 | 39 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2019 | 36 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2021 | 338 | 0.040 |
Why?
|
| Animal Feed | 1 | 2019 | 76 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 106 | 0.040 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 49 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2018 | 312 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 104 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 136 | 0.040 |
Why?
|
| Diet, Protein-Restricted | 1 | 2019 | 82 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 37 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 334 | 0.040 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2018 | 77 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 50 | 0.040 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 297 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 240 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2019 | 340 | 0.030 |
Why?
|
| Morpholinos | 1 | 2016 | 10 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 39 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 101 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2016 | 38 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 172 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 48 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 165 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 412 | 0.030 |
Why?
|
| Manganese | 1 | 2016 | 47 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 94 | 0.030 |
Why?
|
| Malnutrition | 1 | 2019 | 196 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 167 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 350 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 246 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 363 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 409 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 432 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 370 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 190 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 515 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 98 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1338 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1255 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 809 | 0.030 |
Why?
|
| Myotonic Dystrophy | 1 | 2016 | 145 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 740 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 647 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 459 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 455 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 996 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 250 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1315 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2017 | 878 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2012 | 8 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 678 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1197 | 0.020 |
Why?
|
| Diet | 1 | 2019 | 1125 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2012 | 45 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2002 | 87 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 313 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 286 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 617 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2227 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 4221 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1927 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 2947 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3526 | 0.020 |
Why?
|
| Female | 2 | 2019 | 65444 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 239 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 19095 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 268 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 657 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1999 | 9 | 0.010 |
Why?
|
| Apoproteins | 1 | 1999 | 20 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 559 | 0.010 |
Why?
|
| Trypsin | 1 | 1999 | 95 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1999 | 155 | 0.010 |
Why?
|
| Ryanodine | 1 | 1999 | 7 | 0.010 |
Why?
|
| Diamide | 1 | 1999 | 3 | 0.010 |
Why?
|
| Ethylmaleimide | 1 | 1999 | 13 | 0.010 |
Why?
|
| Alkylation | 1 | 1999 | 10 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 1999 | 7 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 752 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 815 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1999 | 54 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 1101 | 0.010 |
Why?
|
| Child | 1 | 2018 | 24225 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 796 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1682 | 0.010 |
Why?
|